Prognostic Enrichment is a clinical trial strategy of evaluating an intervention in a patient population with a higher rate of the unwanted event than the broader patient population (R. Temple (2010) <doi:10.1038/clpt.2010.233>). A higher event rate translates to a lower sample size for the clinical trial, which can have both practical and ethical advantages. This package is a tool to help evaluate biomarkers for prognostic enrichment of clinical trials.
| Version: | 0.2.2 |
| Depends: | R (≥ 3.4.0) |
| Imports: | ggplot2,gridExtra,pROC,VGAM |
| Published: | 2018-07-17 |
| DOI: | 10.32614/CRAN.package.BioPET |
| Author: | Jeremy Roth [cre, aut], Kathleen F. Kerr [aut], Kehao Zhu [aut] |
| Maintainer: | Jeremy Roth <jhroth at uw.edu> |
| License: | GPL-2 |GPL-3 [expanded from: GPL (≥ 2)] |
| NeedsCompilation: | no |
| CRAN checks: | BioPET results |
| Reference manual: | BioPET.html ,BioPET.pdf |
| Package source: | BioPET_0.2.2.tar.gz |
| Windows binaries: | r-devel:BioPET_0.2.2.zip, r-release:BioPET_0.2.2.zip, r-oldrel:BioPET_0.2.2.zip |
| macOS binaries: | r-release (arm64):BioPET_0.2.2.tgz, r-oldrel (arm64):BioPET_0.2.2.tgz, r-release (x86_64):BioPET_0.2.2.tgz, r-oldrel (x86_64):BioPET_0.2.2.tgz |
| Old sources: | BioPET archive |
Please use the canonical formhttps://CRAN.R-project.org/package=BioPETto link to this page.